Noumi Limited (NOU) AI Stock Analysis

• Market Cap: AU$36.02M
• Dividend Yield: N/A
• Average Volume (3M): 58.99K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.45
• Revenue Growth: 1.03%
• EPS Growth: -52.56%
• Country: AU
• Employees: 500
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 0.06
• Shares Outstanding: 277,109,300
• 10 Day Avg. Volume: 37,033
• 30 Day Avg. Volume: 58,993
• PEG Ratio: >-0.01
• Price to Book (P/B): -0.07
• Price to Sales (P/S): 0.05
• P/FCF Ratio: 1.15
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$0.19
• Price Target Upside: 35.71% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 40 Underperform
• Price Target: AU$0.00 ▼(-100.00% Downside)

Noumi Limited's overall stock score reflects significant financial challenges, including negative profitability and high leverage. Technical indicators suggest bearish momentum, while valuation metrics highlight ongoing financial difficulties. The lack of earnings call and corporate events data limits further insights.

Noumi Limited Business Overview & Revenue Model

Company Description

Noumi Limited (NOU) is a diversified company focused on health and wellness solutions, operating primarily in the nutraceuticals and functional foods sectors. The company offers a range of products designed to promote physical and mental well-being, including dietary supplements, plant-based proteins, and wellness beverages. Noumi Limited is committed to innovation and sustainability, providing high-quality products that cater to the growing demand for natural health solutions.

How the Company Makes Money

Noumi Limited generates revenue through the sale of its core products, which include dietary supplements and functional foods. The company's revenue model primarily relies on direct sales to consumers via e-commerce platforms and retail partnerships. Key revenue streams include product sales, subscriptions for regular deliveries of health products, and collaborations with health professionals and fitness centers. Significant partnerships with retailers and online marketplaces enhance its distribution capabilities, driving customer acquisition and increasing sales volume. Additionally, Noumi Limited's focus on brand loyalty and customer retention through high-quality products and customer engagement strategies contributes to its earnings.

Noumi Limited Financial Statement Overview

Summary

Noumi Limited faces significant financial challenges, with a negative net profit margin and declining EBITDA margin. The balance sheet shows high leverage and negative equity, indicating financial instability. While there are some improvements in cash flow, overall financial health remains concerning.

Income Statement

Noumi Limited has shown some improvement in its gross profit margin over the years, reaching 27.14% in 2025, indicating better cost management. However, the company continues to face challenges with profitability, as evidenced by a negative net profit margin of -25.18% and a declining EBITDA margin. Revenue growth has been inconsistent, with a notable increase in 2025, but past fluctuations suggest volatility in sales performance.

Balance Sheet

The balance sheet reveals significant financial instability, with a negative stockholders' equity indicating potential solvency issues. The debt-to-equity ratio is negative, reflecting high leverage and financial risk. Although there is a slight improvement in return on equity, the overall financial health remains concerning due to persistent negative equity.

Cash Flow

Cash flow analysis shows some positive trends, such as a reduction in negative free cash flow and an improvement in operating cash flow. However, the operating cash flow to net income ratio remains low, indicating challenges in converting income into cash. The free cash flow to net income ratio is relatively high, suggesting some efficiency in cash management despite overall financial struggles.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	595.84M	595.84M	589.79M	551.56M	522.34M	547.29M
Gross Profit	161.72M	161.72M	145.75M	134.77M	98.42M	93.53M
EBITDA	-50.33M	-138.96M	-61.24M	-6.37M	-122.53M	28.01M
Net Income	-150.00M	-150.00M	-98.33M	-46.91M	-160.74M	-53.18M
Balance Sheet
Total Assets	265.17M	265.17M	316.20M	377.95M	420.13M	538.67M
Cash, Cash Equivalents and Short-Term Investments	23.18M	23.18M	21.57M	18.56M	16.21M	31.67M
Total Debt	614.75M	614.75M	533.76M	491.00M	455.01M	462.39M
Total Liabilities	717.51M	717.51M	621.14M	581.49M	569.14M	537.18M
Stockholders Equity	-452.34M	-452.34M	-304.94M	-203.54M	-149.01M	1.49M
Cash Flow
Free Cash Flow	27.66M	27.66M	11.02M	-49.00K	-46.87M	-56.67M
Operating Cash Flow	32.52M	32.52M	15.83M	4.31M	-40.86M	-54.01M
Investing Cash Flow	2.09M	2.09M	1.84M	2.22M	-3.93M	13.50M
Financing Cash Flow	-33.01M	-33.01M	-21.64M	-4.18M	29.33M	53.80M

Noumi Limited Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.14
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NOU, the sentiment is Neutral. The current price of 0.14 is above the 20-day moving average (MA) of 0.14, below the 50-day MA of 0.15, and below the 200-day MA of 0.15, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 51.31 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:NOU.

Noumi Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
HCT	43 Neutral	AU$26.13M	33.91	―	―	6.76%	―
AHF	41 Neutral	€30.48M	―	-20.54%	―	13.92%	36.28%
NUC	41 Neutral	AU$20.23M	5.77	-29.43%	―	102.21%	69.47%
NOU	40 Underperform	AU$36.02M	―	―	―	1.03%	-52.56%
WNX	40 Underperform	€13.99M	―	-184.71%	―	39.53%	49.99%

Noumi Limited Corporate Events

Noumi Limited Reports Mixed Q4 FY25 Results Amid Legal and Market Challenges

Noumi Limited reported a slight decline in Q4 FY25 revenue to $155.2 million, with plant-based milks experiencing a 2.9% decrease, while dairy and nutritionals saw a 0.9% increase. Despite a negative operating cash flow of $2.2 million due to legal expenses, the company maintained a positive annual operating cash flow of $32.5 million. Noumi is optimistic about its FY25 earnings, expecting improved operating EBITDA, although it anticipates a net loss after tax due to depreciation, financing costs, and impairment charges. The company continues to see strong performance from its Milklab brand, particularly in retail and export channels, despite competitive pressures and macroeconomic challenges.

The most recent analyst rating on (AU:NOU) stock is a Buy with a A$0.17 price target. To see the full list of analyst forecasts on Noumi Limited stock, see the AU:NOU Stock Forecast page.

Noumi Limited Resolves Class Action, Paves Way for Future Growth

Noumi Limited has announced that the Victorian Supreme Court has approved the settlement terms of a class action lawsuit, marking the resolution of a significant legacy issue for the company. With the settlement, which includes Noumi’s $11.56 million contribution covered by insurance, the company can now focus on business growth and enhancing stakeholder value, as it moves past the financial restatements of FY19 and FY20.

The most recent analyst rating on (AU:NOU) stock is a Buy with a A$0.17 price target. To see the full list of analyst forecasts on Noumi Limited stock, see the AU:NOU Stock Forecast page.